The link between glutamate and migraine

CNS Spectrums

Volumn 8, Issue 6, 2003, Pages 446-449

  Ramadan, Nabih M ^a,b  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; KAINIC ACID; KAINIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

HUMAN; MIGRAINE; NEUROCHEMISTRY; NEUROMODULATION; NOCICEPTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SPREADING CORTICAL DEPRESSION; THALAMUS; TRIGEMINAL NUCLEUS; TRIGEMINUS GANGLION;

EID: 0038799954     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900018757     Document Type: Review

References (29)

1. Bleakman D, Lodge D. Neuropharmacology of AMPA and kainate receptors. Neuropharmacology. 1998;37:1187-1204.
2. Fundytus ME. Glutamate receptors and nociception: implications for the drug treatment of pain. CNS Drugs. 2001;15:29-58.
3. Schoepp DD, Conn PJ. Metabotropic glutamate receptor in brain function and pathology. Trends Pharmacol Sci. 1993;14:13-20.
4. Hill RG, Salt TE. An ionophoretic study of the responses of rat caudal trigeminal nucleus neurons to non-noxious mechanical sensory stimuli. J Physiol. 1982;327:65-78.
5. Bereiter D.A. and Benetti, A.P. Excitatory amino acid release within spinal trigeminal nucleus after mustard oil injection into the temporomandibular joint region of the rat. Pain. 1996;67:451-459.
6. Sahara Y, Noro N, Iida Y, Soma K, Nakamura Y. Glutamate receptor subunits GluR5 and KA-2 are coexpressed in rat trigeminal ganglion neurons. J Neurosci. 1997;17:6611-6620.
7. Quartu M, Serra MP, Ambu R, Lai ML, Del Fiacco M. AMPA-type glutamate receptor subunits 2/3 in the human trigeminal sensory ganglion and subnucleus caudalis from prenatal ages to adulthood. Mech Ageing Dev. 2002;123:463-471.
8. Tallaksen-Greene SJ, Young AB, Penney JB, Beitz AJ. Excitatory amino acid binding sites in the trigeminal principal sensory and spinal trigeminal nuclei of the rat. Neurosci Lett. 141:79-83.
9. Ma QP. Co-localization of 5-HT (1B/1D/1F) receptors and glutamate in trigeminal ganglia in rats. Neuroreport. 2001;12:1589-1591.
10. Scheller D, Szathmary S, Kolb J, Tegtmeier F. Observations on the relationship between the extracellular changes of taurine and glutamate during cortical spreading depression, during ischemia, and within the area surrounding a thrombotic infarct. Amino Acids. 2000;19:571-583.
11. Lauritzen M, Hansen AJ. The effect of glutamate receptor blockade on anoxic depolarization and cortical spreading depression. J Cereb Blood Flow Metab. 1992;12:223-229.
12. Obrenovitch TP, Zilkha E, Urenjak J. Evidence against high extracellular glutamate promoting the elicitation of spreading depression by potassium. J Cereb Blood Flow Metab. 1996;16:923-931.
13. Mody I, Lambert JD, Heinemann U. Low extracellular magnesium induces epileptiform activity and spreading depression in rat hippocampal slices. J Neurophysiol. 1987;57:869-888.
14. Nellgard B, Wieloch T. NMDA-receptor blockers but not NBQX, an AMPA-receptor antagonist, inhibit spreading depression in the rat brain. Acta Physiol Scand. 1992;146:497-503.
15. Johnson KW, Dieckman DK, Phebus LA, et al. iGluR5 antagonists as novel migraine therapies [abstract]. Cephalalgia. 2001;21:268.
16. Mitsikostas DD, Sanchez del Rio M, Waeber C, Huang Z, Cutrer FM, Moskowitz MA. Non-NMDA glutamate receptors modulate capsaicin induced c-fos expression within trigeminal nucleus caudalis. Br J Pharmacol. 1999;127:623-630.
17. Goadsby PJ, Classey JD. Glutamatergic transmission in the trigeminal nucleus assessed with local blood flow. Brain Res. 2000;875:119-124.
18. Storer RJ, Goadsby PJ. Trigeminovascular nociceptive transmission involves N-methyl-D-aspartate and non-N-methyl-D-aspartate glutamate receptors. Neuroscience. 1999;90:1371-1376.
19. Ferrari MD, Odink J, Bos KD, Malessy MJ, Bruyn GW. Neuroexcitatory plasma amino acids are elevated in migraine. Neurology. 1990;40:1582-1586.
20. D'Andrea G, Cananzi AR, Joseph R, et al. Platelet glycine, glutamate and aspartate in primary headache. Cephalalgia. 1991;11:197-200.
21. Martinez F, Castillo J, Rodriguez JR, Leira R, Noya M. Neuroexcitatory amino acid levels in plasma and cerebrospinal fluid during migraine attacks. Cephalalgia. 1993;13:89-93.
22. Cananzi AR, D'Andrea G, Perini F, Zamberlan F, Welch KM. Platelet and plasma levels of glutamate and glutamine in migraine with and without aura. Cephalalgia. 1995;15:132-135.
23. D'Eufemia P, Finocchiaro R, Lendvai D, et al. Erythrocyte and plasma levels of glutamate and aspartate in children affected by migraine. Cephalalgia. 1997;17:652-657
24. Alam Z, Coombes N, Waring RH, Williams AC, Steventon GB. Plasma levels of neuroexcitatory amino acids in patients with migraine or tension headache. J Neurol Sci. 1998;156:102-106.
25. Burnstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ, Bajwa ZH. An association between migraine and cutaneous allodynia. Ann Neurol. 2000;47:614-624.
26. Burstein R. Deconstructing migraine headache into peripheral and central sensitization. Pain. 2001;89:107-110.
27. Katsarava Z, Lehnerdt G, Duda B, Ellrich J, Diener HC, Kaube H. Sensitization of trigeminal nociception specific for migraine but not pain of sinusitis. Neurology. 2002;59:1450-1453.
28. Kaube H, Herzog J, Kaufer T, Dichgans M, Diener HC. Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine. Neurology. 2000;55:139-141.
29. Ramadan N, Sang C, Chappell A, et al. IV LY293558, an AMPA/KA receptor antagonist, is effective in migraine [abstract]. Cephalalgia. 2001;21:267-268.